The Role of Adjuvant Therapy in Gastrointestinal Stromal Tumor after Operative Treatment

被引:0
作者
Lok, Ka-Ho [1 ]
机构
[1] Tuen Mun Hosp, Dept Med & Geriatr, Div Gastroenterol & Hepatol, Hong Kong, Hong Kong, Peoples R China
关键词
GIST; adjuvant; imatinib; operative;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The treatment for localized advance gastrointestinal stromal tumor (GIST) is far from ideal. Up to 50% of patient developed post-operative recurrence and died within 5 years. Recently, imatinib was found to significantly improve recurrence-free survival in post-operative patients. The role of adjuvant therapy in high risk GIST patients is discussed.
引用
收藏
页码:25 / 27
页数:3
相关论文
共 15 条
[1]  
BANDOH T, 1993, SURGERY, V113, P498
[2]   Gastrointestinal stromal tumours:: Consensus statement on diagnosis and treatment [J].
Blackstein, ME ;
Blay, JY ;
Corless, C ;
Driman, DK ;
Riddell, R ;
Soulières, D ;
Swallow, CJ ;
Verma, S .
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (03) :157-163
[3]   Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up [J].
Casali, P. G. ;
Jost, L. ;
Reichardt, P. ;
Schlemmer, M. ;
Blay, J. -Y. .
ANNALS OF ONCOLOGY, 2008, 19 :35-38
[4]   Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) [J].
DeMatteo, Ronald P. ;
Gold, Jason S. ;
Saran, Lisa ;
Goenen, Mithat ;
Liau, Kui Hin ;
Maki, Robert G. ;
Singer, Samuel ;
Besmer, Peter ;
Brennan, Murray F. ;
Antonescu, Cristina R. .
CANCER, 2008, 112 (03) :608-615
[5]   Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].
DeMatteo, Ronald P. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Demetri, George D. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Brennan, Murray F. ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Polikoff, Jonathan A. ;
Tan, Benjamin R. ;
Owzar, Kouros .
LANCET, 2009, 373 (9669) :1097-1104
[6]   Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].
DeMatteo, RP ;
Lewis, JJ ;
Leung, D ;
Mudan, SS ;
Woodruff, JM ;
Brennan, MF .
ANNALS OF SURGERY, 2000, 231 (01) :51-58
[7]   Clinical management of gastrointestinal stromal tumors: Before and after STI-571 [J].
DeMatteo, RP ;
Heinrich, MC ;
El-Rifai, WM ;
Demetri, G .
HUMAN PATHOLOGY, 2002, 33 (05) :466-477
[8]   PDGFRA activating mutations in gastrointestinal stromal tumors [J].
Heinrich, MC ;
Corless, CL ;
Duensing, A ;
McGreevey, L ;
Chen, CJ ;
Joseph, N ;
Singer, S ;
Griffith, DJ ;
Haley, A ;
Town, A ;
Demetri, GD ;
Fletcher, CDM ;
Fletcher, JA .
SCIENCE, 2003, 299 (5607) :708-710
[9]   Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors [J].
Hirota, S ;
Isozaki, K ;
Moriyama, Y ;
Hashimoto, K ;
Nishida, T ;
Ishiguro, S ;
Kawano, K ;
Hanada, M ;
Kurata, A ;
Takeda, M ;
Tunio, GM ;
Matsuzawa, Y ;
Kanakura, Y ;
Shinomura, Y ;
Kitamura, Y .
SCIENCE, 1998, 279 (5350) :577-580
[10]   Management of malignant gastrointestinal stromal tumours [J].
Joensuu, H ;
Fletcher, C ;
Dimitrijevic, S ;
Silberman, S ;
Roberts, P ;
Demetri, G .
LANCET ONCOLOGY, 2002, 3 (11) :655-664